In MCI and mild AD, NGF receptors TrkA and p75NTR are reduced by ~50%. ProNGF levels increase by 40-60% in cortical regions during MCI and AD. TrkA reduction correlates with cognitive decline (MMSE scores). NGF receptor downregulation suggests a phenotypic silencing during early AD stages. Here, NTRK1 is linked to Alzheimer disease.